Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.77
0.03 (4.58%)
At close: Aug 15, 2025, 10:05 AM

Context Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.3 -0.75 -0.7 -0.72
PEG Ratio
0.03 -0.01 0.01 0.00
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.64 1.52 0.30 0.16
P/FCF Ratio
-2.09 -0.86 -0.74 -0.83
P/OCF Ratio
-4.21 -0.86 -0.77 -0.86
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.00 n/a 0.00 n/a
Quick Ratio
35.62 3.83 11.80 16.90
Current Ratio
35.62 3.83 11.80 16.90
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a -28.11 -163.85
Return on Equity
-0.28 -2.02 -0.43 -0.22
Return on Assets
-0.27 -1.49 -0.39 -0.2
Return on Invested Capital
-0.31 -2.11 -0.44 -0.22
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a